Guardant Health Enters Material Definitive Agreement
Ticker: GH · Form: 8-K · Filed: Aug 23, 2024 · CIK: 1576280
| Field | Detail |
|---|---|
| Company | Guardant Health, Inc. (GH) |
| Form Type | 8-K |
| Filed Date | Aug 23, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.00001, $400.0 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement
TL;DR
Guardant Health signed a big deal, details TBD.
AI Summary
Guardant Health, Inc. announced on August 23, 2024, that it has entered into a material definitive agreement. The filing does not disclose specific details of the agreement, the counterparty, or any associated financial figures. Further information is expected to be provided in subsequent filings or exhibits.
Why It Matters
This filing indicates a significant new business development for Guardant Health, which could impact its future operations and financial performance.
Risk Assessment
Risk Level: medium — The lack of specific details in this 8-K filing creates uncertainty about the nature and implications of the material definitive agreement.
Key Players & Entities
- Guardant Health, Inc. (company) — Registrant
- August 23, 2024 (date) — Date of earliest event reported
FAQ
What is the nature of the material definitive agreement entered into by Guardant Health?
The filing does not specify the nature of the material definitive agreement.
Who is the counterparty to this material definitive agreement?
The filing does not disclose the identity of the counterparty.
Are there any financial terms or obligations associated with this agreement?
The filing does not provide any details regarding financial terms or obligations.
When was the agreement officially entered into?
The report indicates August 23, 2024, as the date of the earliest event reported, which is presumed to be the entry into the agreement.
Where can I find more details about this agreement?
Further details are expected to be disclosed in exhibits or subsequent filings, as indicated by the filing type.
Filing Stats: 994 words · 4 min read · ~3 pages · Grade level 11.4 · Accepted 2024-08-23 16:10:54
Key Financial Figures
- $0.00001 — nge on which registered Common Stock, $0.00001 par value per share GH The Nasdaq G
- $400.0 million — aving aggregate gross proceeds of up to $400.0 million (the "Shares") through the Agent, actin
Filing Documents
- d870565d8k.htm (8-K) — 29KB
- d870565dex11.htm (EX-1.1) — 198KB
- d870565dex51.htm (EX-5.1) — 8KB
- g870565snap1.jpg (GRAPHIC) — 9KB
- g870565snap2.jpg (GRAPHIC) — 11KB
- g870565snap3.jpg (GRAPHIC) — 10KB
- 0001193125-24-206179.txt ( ) — 452KB
- gh-20240823.xsd (EX-101.SCH) — 3KB
- gh-20240823_lab.xml (EX-101.LAB) — 17KB
- gh-20240823_pre.xml (EX-101.PRE) — 11KB
- d870565d8k_htm.xml (XML) — 3KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 1.1 Open Market Sale Agreement SM by and between the Company and Jefferies LLC, dated August 23, 2024. 5.1 Opinion of Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP. 23.1 Consent of Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP (included in Exhibit 5.1). 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. GUARDANT HEALTH, INC. Date: August 23, 2024 By: /s/ John G. Saia John G. Saia Chief Legal Officer and Corporate Secretary